Best: Biotech Etf To Buy Now

Strategy: Actively managed by Cathie Wood's team, targeting "disruptive" innovation . Expense Ratio: 0.75% . Comparison of Key Metrics 1-Year Return Expense Ratio Small/Mid-Cap Equal Weight IBB Large-Cap Market Weighted SBIO Clinical Trial Breakthroughs IBBQ Nasdaq Biotech Index Data based on recent 2026 market reports .

Best for: Speculative bets on high-frontier tech like gene editing and CRISPR . best biotech etf to buy now

Strategy: Market-cap weighted, dominated by giants like Vertex, Gilead, and Amgen . Expense Ratio: 0.44% . Best for: Low-cost core exposure . Strategy: Actively managed by Cathie Wood's team, targeting